Method for non-invasive monitoring of fluorescent tracer agent with diffuse reflection corrections
AssigneeMediBeacon Inc.
InventorsKimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
Life of this patent
Estimating the term…
Loading patent…
AssigneeMediBeacon Inc.
InventorsKimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
Estimating the term…
A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DRex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DRem signal detected by the unfiltered light detector during illumination by emission-wavelength light. The method further includes identifying a post-agent administration portion of the measurement data set; and transforming each Flr signal to an IF signal representing a detected fluorescence intensity emitted solely by the fluorescent agent.
A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties, the method comprising:
(canceled)
Dependencies are inferred from the claim text.